Scinai Immunotherapeutics Ltd Revenue per Employee (SCNI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Scinai Immunotherapeutics Ltd  (NASDAQ: SCNI)
 

Scinai Immunotherapeutics Ltd's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Scinai Immunotherapeutics Ltd's Revenue per employee grew on a trailing twelve month basis to , the productivity of Scinai Immunotherapeutics Ltd's employees reached a new high of $ 12,606.
Within the Healthcare sector Employees of 565 other companies have achieved higher revenue per employee. While Scinai Immunotherapeutics Ltd's total ranking has deteriorated compared to the previous quarter from to 3918. Scinai Immunotherapeutics Ltd has 104 employees.


What is Sales per Employee Ratio?







SCNI Revenue per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 12,606 - - - -
SCNI's Total Ranking # 3918 # # # #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 74
Healthcare Sector # 566
Overall Market # 3918

Revenue per Employee Statistics
High Average Low
$ 12,606 $ 12,606 $ 12,606
(Dec 31 2025)  



Financial Statements
Scinai Immunotherapeutics Ltd's Revenue MRQ $ 1 Millions Visit SCNI's Income Statement
Scinai Immunotherapeutics Ltd's Revenues TTM $ 1 Millions Visit SCNI's aggregate revenue growth
What are SCNI's Sales? Visit SCNI's Sales by Segment




Other Ratios
Scinai Immunotherapeutics Ltd's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SCNI's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SCNI's Competitors
Revenue per Employee for SCNI's Suppliers
Revenue per Employee for SCNI's Customers

You may also want to know
SCNI's Sales Growth Rates SCNI's Pe Price to earnings ratio SCNI's Receivables Turnover Ratio SCNI's Stock Quote
SCNI's Net Income Growth Rates SCNI's Ps Price to Sales ratio SCNI's Sales per Employee SCNI's Asset Turnover Ratio
SCNI's Net Margin SCNI's Pb Price to Book ratio SCNI's Financial Strength Ratios SCNI's Dividend Payout Ratio
Date modified: 2026-07-07T13:25:31+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Mangoceuticals Inc   20,728.23 $ 0.456  Million 22 
Ataibeckley Inc   20,242.57 $ 4.089  Million 202 
Onemednet Corporation  20,043.48 $ 0.461  Million 23 
Absci Corp  20,000.00 $ 2.800  Million 140 
Oculis Holding Ag  19,983.33 $ 1.199  Million 60 
Vistagen Therapeutics Inc   19,268.29 $ 0.790  Million 41 
Cardiff Oncology Inc   19,129.03 $ 0.593  Million 31 
China Pharma Holdings Inc  18,752.36 $ 4.144  Million 221 
Roivant Sciences Ltd   17,746.67 $ 13.310  Million 750 
Crispr Therapeutics Ag  17,462.69 $ 3.510  Million 201 
Lyra Therapeutics Inc   14,740.74 $ 0.398  Million 27 
Northwest Biotherapeutics Inc  13,123.81 $ 1.378  Million 105 
Crinetics Pharmaceuticals Inc   12,956.23 $ 7.696  Million 594 
Scinai Immunotherapeutics Ltd  12,605.77 $ 1.311  Million 104 
Redhill Biopharma Ltd   11,916.67 $ 0.286  Million 24 
Skinvisible Inc   10,000.00 $ 0.020  Million
Lightwave Logic Inc   6,966.32 $ 0.237  Million 34 
Aclarion Inc   6,884.55 $ 0.076  Million 11 
Silence Therapeutics Plc  6,352.27 $ 0.559  Million 88 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.